Skip to main content
SINPHAR logo

SINPHAR — Investor Relations & Filings

Ticker · 1734 ISIN · TW0001734002 TW Manufacturing
Open in API
Filings indexed 1,611 across all filing types
Latest filing 2021-05-10 Regulatory Filings
Country TW Taiwan
Listing TW 1734

About SINPHAR

www.sinphar.com

Sinphar Pharmaceutical Co., Ltd. is a vertically integrated pharmaceutical group specializing in the research, development, manufacturing, and distribution of therapeutic medicines, nutraceuticals, and medical cosmetics. Established in 1977, the company produces a diverse range of products, including Western and Chinese pharmaceuticals, specialized oncology drugs, and health supplements. Sinphar operates advanced R&D facilities and an ISO 17025-certified laboratory, leveraging high-precision technology for product innovation and quality assurance. Its business model encompasses proprietary brand management alongside professional OEM and ODM services for international markets. Key areas of expertise include the development of cancer treatments, functional health foods, and medical-grade skincare. Through its global marketing network and dedicated retail counters, Sinphar provides comprehensive healthcare solutions focused on life, health, and technology.

Recent filings

Filing Released Lang Actions
110年4月背書保證與資金貸與
Regulatory Filings Classification · 90% confidence The document contains financial data related to guarantees and endorsements, with monthly and cumulative amounts, but it is very short (615 characters) and does not contain comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure of financial guarantees rather than a full report. There is no indication of it being an annual or interim report, audit report, or other detailed filings. Given the brevity and nature of the data, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2021-05-10 Chinese
110年4月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a summary report of monthly and cumulative net operating revenue figures for a company named 杏輝, presented in a tabular format with explanations about accounting standards and reporting practices. The document length is short (766 characters) and it does not contain detailed financial statements or comprehensive analysis. It appears to be a brief financial data disclosure rather than a full financial report. There is no indication that this is an announcement of a report publication or a certification. Given the nature of the content as a brief financial summary and the short length, it fits best as a Fund Information / Factsheet (FS) type, which is a brief summary of key company financials and market info.
2021-05-10 Chinese
本公司董事會決議通過110年度第一季合併財務報告案
Regulatory Filings Classification · 95% confidence The document is a brief announcement from a listed company (1734 杏輝) regarding the board's resolution to approve the consolidated financial report for the first quarter of the year 110 (Taiwan calendar, corresponding to 2021). It includes summarized financial data such as revenue, gross profit, operating loss, net profit/loss, earnings per share, total assets, liabilities, and equity for the period 110/01/01 to 110/03/31. The document is short (897 characters) and primarily serves as a notification of the board's approval of the quarterly financial report rather than the full report itself. There is no detailed financial statement or substantive analysis included, only key figures and dates. According to the rules, such a document is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement of the board's approval of the quarterly financial report, not the report itself (which would be an Interim/Quarterly Report IR).
2021-05-07 Chinese
110年03月內部人持股異動(事後)
Director's Dealing Classification · 95% confidence The document contains detailed tables listing shareholdings of company insiders, including directors, supervisors, general managers, and their family members. It shows the number of shares held, changes in holdings, and other related data. There is no indication of financial statements, earnings data, management discussion, or legal proceedings. The content is focused on insider shareholdings and transactions. This matches the definition of Director's Dealing (DIRS), which reports personal share transactions by company directors and executives (insider trades). The document length is substantial and contains actual data, not just an announcement or certification. Therefore, the appropriate classification is DIRS.
2021-04-13 Chinese
110年03月董事會成員及持股
Director's Dealing Classification · 95% confidence The document is a detailed tabulation of shareholdings by insiders and related parties of the company 杏輝藥品工業股份有限公司. It lists the number of shares held by directors, supervisors, and senior management, including pledged shares and shares held by spouses or minors. There is no indication of financial statements, earnings data, or report publication. The content focuses on insider shareholdings and their changes, which aligns with disclosures about personal share transactions or holdings by company directors and executives. Therefore, this document fits the category of Director's Dealing (DIRS). The document length is 3344 characters, which is consistent with a detailed insider shareholding report rather than a brief announcement or a full financial report.
2021-04-13 Chinese
110年3月背書保證與資金貸與
Regulatory Filings Classification · 90% confidence The document contains financial data related to the company's guarantees and loans, including amounts for the current and previous months, and maximum limits. It is a short report (615 characters) with tabulated financial information but does not include comprehensive financial statements or detailed analysis. It is not an announcement of a report but a brief financial disclosure. The content fits best with a Regulatory Filings (RNS) category as it provides regulatory-required financial disclosures that do not constitute a full financial report or other specific filing types.
2021-04-09 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.